Correlation Between Moberg Pharma and Q Linea

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moberg Pharma and Q Linea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moberg Pharma and Q Linea into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moberg Pharma AB and Q linea AB, you can compare the effects of market volatilities on Moberg Pharma and Q Linea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moberg Pharma with a short position of Q Linea. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moberg Pharma and Q Linea.

Diversification Opportunities for Moberg Pharma and Q Linea

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Moberg and QLINEA is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Moberg Pharma AB and Q linea AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Q linea AB and Moberg Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moberg Pharma AB are associated (or correlated) with Q Linea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Q linea AB has no effect on the direction of Moberg Pharma i.e., Moberg Pharma and Q Linea go up and down completely randomly.

Pair Corralation between Moberg Pharma and Q Linea

Assuming the 90 days trading horizon Moberg Pharma is expected to generate 1.83 times less return on investment than Q Linea. But when comparing it to its historical volatility, Moberg Pharma AB is 2.07 times less risky than Q Linea. It trades about 0.09 of its potential returns per unit of risk. Q linea AB is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  3,990  in Q linea AB on April 24, 2025 and sell it today you would earn a total of  740.00  from holding Q linea AB or generate 18.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Moberg Pharma AB  vs.  Q linea AB

 Performance 
       Timeline  
Moberg Pharma AB 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Moberg Pharma AB are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Moberg Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.
Q linea AB 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Q linea AB are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak forward indicators, Q Linea sustained solid returns over the last few months and may actually be approaching a breakup point.

Moberg Pharma and Q Linea Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moberg Pharma and Q Linea

The main advantage of trading using opposite Moberg Pharma and Q Linea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moberg Pharma position performs unexpectedly, Q Linea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Q Linea will offset losses from the drop in Q Linea's long position.
The idea behind Moberg Pharma AB and Q linea AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Correlations
Find global opportunities by holding instruments from different markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated